SEARCH
= Registered usersSavill. Omega-3 PUFAs of little benefit in secondary prevention. Practitioner 2014 ; 258 (1769): 7
Omega-3 PUFAs of little benefit in secondary prevention
20 Mar 2014
The use of omega-3 polyunsaturated fatty acid (PUFA) supplements in patients with coronary heart disease (CHD) does not reduce major cardiovascular events, a large meta-analysis has found. Fourteen randomised controlled trials were analysed. Overall, 16,338 CHD patients received omega-3 PUFAs and 16,318 patients acted as controls.
This article can be accessed only if you are a paid-up subscriber to The Practitioner.